Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.10 per share
-
Shares outstanding
-
2.05B
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
2.43M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$6.69M
-
Value change
-
+$2.77M
-
Number of buys
-
12
-
Number of sells
-
-9
-
Price
-
$2.75
Significant Holders of BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) as of Q3 2021
36 filings reported holding BLRX - BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share as of Q3 2021.
BioLineRx Ltd. - Ordinary shares, par value NIS 0.10 per share (BLRX) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.43M shares
of 2.05B outstanding shares and own 0.12% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (1.07M shares), Parkman Healthcare Partners LLC (411K shares), MORGAN STANLEY (240K shares), CITADEL ADVISORS LLC (165K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (77.7K shares), PVG ASSET MANAGEMENT CORP (76.5K shares), LPL Financial LLC (66.1K shares), ENVESTNET ASSET MANAGEMENT INC (42.9K shares), GEODE CAPITAL MANAGEMENT, LLC (32K shares), and Intellectus Partners, LLC (28.5K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.